Stocks and Investing
Stocks and Investing
Mon, July 31, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CC) at Hold with Increased Target to $40 on, Jul 31st, 2023
Arun Viswanathan of RBC Capital, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $37 to $40 on, Jul 31st, 2023.
Arun has made no other calls on CC in the last 4 months.
There are 7 other peers that have a rating on CC. Out of the 7 peers that are also analyzing CC, 4 agree with Arun's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Reiterated at Hold and Held Target at $33 on, Wednesday, July 19th, 2023
- Michael Leithead of "Barclays" Maintained at Hold with Increased Target to $40 on, Tuesday, July 11th, 2023
- Matthew DeYoe of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $37 on, Thursday, June 22nd, 2023
- Jeffrey Zekauskas of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Wednesday, May 31st, 2023
These are the ratings of the 3 analyists that currently disagree with Arun
- Joshua Spector of "UBS" Maintained at Strong Buy with Increased Target to $43 on, Tuesday, June 13th, 2023
- John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $64 on, Monday, June 5th, 2023
- John Roberts of "Credit Suisse" Maintained at Sell with Decreased Target to $25 on, Friday, April 28th, 2023
Contributing Sources